Ivan N. Rich

1.4k total citations
52 papers, 1.0k citations indexed

About

Ivan N. Rich is a scholar working on Hematology, Physiology and Molecular Biology. According to data from OpenAlex, Ivan N. Rich has authored 52 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 19 papers in Physiology and 16 papers in Molecular Biology. Recurrent topics in Ivan N. Rich's work include Erythropoietin and Anemia Treatment (16 papers), Erythrocyte Function and Pathophysiology (14 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Ivan N. Rich is often cited by papers focused on Erythropoietin and Anemia Treatment (16 papers), Erythrocyte Function and Pathophysiology (14 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Ivan N. Rich collaborates with scholars based in Germany, United States and United Kingdom. Ivan N. Rich's co-authors include B. Kubanek, Diana Worthington‐White, G Sawatzki, Oliver A. Garden, Philip Musk, S. Pentz, Christina Vogt, Gary Van Zant, Gerald de Haan and Frank Zimmermann and has published in prestigious journals such as Blood, Development and Journal of Applied Physiology.

In The Last Decade

Ivan N. Rich

51 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan N. Rich Germany 19 370 329 243 200 148 52 1.0k
M. Smith United States 17 332 0.9× 545 1.7× 161 0.7× 85 0.4× 157 1.1× 22 1.2k
George Lam United States 15 239 0.6× 639 1.9× 144 0.6× 75 0.4× 127 0.9× 22 1.0k
P Thomopoulos France 24 180 0.5× 635 1.9× 229 0.9× 162 0.8× 121 0.8× 76 1.5k
A. Siflinger-Birnboim United States 16 196 0.5× 513 1.6× 281 1.2× 91 0.5× 162 1.1× 19 1.2k
Morey L. Smith United States 15 213 0.6× 701 2.1× 124 0.5× 148 0.7× 210 1.4× 29 1.3k
Laura J. Bloem United States 20 210 0.6× 825 2.5× 71 0.3× 108 0.5× 155 1.0× 32 1.7k
Philippe Ohlmann France 27 1.3k 3.6× 517 1.6× 161 0.7× 145 0.7× 201 1.4× 53 2.5k
Lee Fy Taiwan 10 180 0.5× 428 1.3× 191 0.8× 58 0.3× 70 0.5× 29 844
L Chao United States 23 338 0.9× 544 1.7× 65 0.3× 904 4.5× 149 1.0× 57 1.6k
Klaas J. Wierenga United States 21 270 0.7× 579 1.8× 137 0.6× 320 1.6× 45 0.3× 43 1.4k

Countries citing papers authored by Ivan N. Rich

Since Specialization
Citations

This map shows the geographic impact of Ivan N. Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan N. Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan N. Rich more than expected).

Fields of papers citing papers by Ivan N. Rich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan N. Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan N. Rich. The network helps show where Ivan N. Rich may publish in the future.

Co-authorship network of co-authors of Ivan N. Rich

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan N. Rich. A scholar is included among the top collaborators of Ivan N. Rich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan N. Rich. Ivan N. Rich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patterson, John B., et al.. (2015). Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units. Journal of Translational Medicine. 13(1). 94–94. 11 indexed citations
2.
Rich, Ivan N., et al.. (2014). Measuring the Potency of a Stem Cell Therapeutic. Methods in molecular biology. 1235. 33–48. 4 indexed citations
3.
Hrushesky, William J.M. & Ivan N. Rich. (2014). Measuring Stem Cell Circadian Rhythm. Methods in molecular biology. 1235. 81–95. 6 indexed citations
4.
Reems, Jo‐Anna, et al.. (2008). Development of a novel assay to evaluate the functional potential of umbilical cord blood progenitors. Transfusion. 48(4). 620–628. 11 indexed citations
5.
Rich, Ivan N.. (2007). High-throughputin vitrohemotoxicity testing andin vitrocross-platform comparative toxicity. Expert Opinion on Drug Metabolism & Toxicology. 3(2). 295–307. 11 indexed citations
6.
7.
Lamb, Lawrence S., et al.. (2002). Assessment of G-CSF stimulated BM hematopoietic stem cells in normal donors. Cytotherapy. 4(1). 55–63. 12 indexed citations
8.
Kubanek, B., et al.. (1999). An ELISA specific for murine erythropoietin. British Journal of Haematology. 104(4). 838–840. 8 indexed citations
9.
Rich, Ivan N.. (1998). Homeobox Genes and Hematopoiesis: An Emerging Picture for Genomic Therapy. Journal of Hematotherapy. 7(6). 515–520. 1 indexed citations
10.
11.
Lappin, T. R. J. & Ivan N. Rich. (1996). Erythropoietin-the first 90 years. Clinical & Laboratory Haematology. 18(3). 137–145. 13 indexed citations
12.
Rich, Ivan N.. (1995). Hemopoietic-initiating cells. Journal of Perinatal Medicine. 23(1-2). 31–38. 7 indexed citations
13.
Rich, Ivan N.. (1994). Introduction: Developmental Biology of Erythropoiesis. Annals of the New York Academy of Sciences. 718(1). 123–124. 1 indexed citations
14.
Schrezenmeier, Hubert, et al.. (1994). Serum erythropotietin and serum transferrin receptor levels in aplastic anaemia. British Journal of Haematology. 88(2). 286–294. 26 indexed citations
15.
Gebicke‐Haerter, Peter J., Kurt Appel, Glen Taylor, et al.. (1994). Rat microglial interleukin-3. Journal of Neuroimmunology. 50(2). 203–214. 45 indexed citations
16.
Rich, Ivan N.. (1988). Haemopoietic Regulation and the Role of the Macrophage in Erythropoietic Gene Expression. Advances in experimental medicine and biology. 241. 55–66. 1 indexed citations
17.
Rich, Ivan N., et al.. (1981). Release of erythropoietin from macrophages by treatment with silica. PubMed. 15(2). 169–176. 6 indexed citations
18.
Rich, Ivan N., W. Heit, & B. Kubanek. (1980). The effect of actinomycin D on hemopoiesis. Annals of Hematology. 41(1). 29–40. 2 indexed citations
19.
Rich, Ivan N., W. Heit, & B. Kubanek. (1979). An erythropoietic stimulating factor similar to erythropoietin released by macrophages after treatment with silica. Annals of Hematology. 40(5). 297–303. 9 indexed citations
20.
Rich, Ivan N. & B. Kubanek. (1976). Erythroid colony formation (CFUe) in fetal liver and adult bone marrow and spleen from the mouse. Annals of Hematology. 33(3). 171–180. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Smith Breakdown of academic impact, for papers by George Lam Breakdown of academic impact, for papers by P Thomopoulos Breakdown of academic impact, for papers by A. Siflinger-Birnboim Breakdown of academic impact, for papers by Morey L. Smith Breakdown of academic impact, for papers by Laura J. Bloem Breakdown of academic impact, for papers by Philippe Ohlmann Breakdown of academic impact, for papers by Lee Fy Breakdown of academic impact, for papers by L Chao Breakdown of academic impact, for papers by Klaas J. Wierenga
Rankless by CCL
2026